Skip to main content
. 2023 Jan 11;11(1):179. doi: 10.3390/biomedicines11010179

Table 1.

Patient characteristics: age, sex (female/male), body mass index (BMI), blood pressure (millimeters of mercury—mmHg), glycated hemoglobin (HbA1c), high-density lipoprotein (HDL), low-density lipoprotein (LDL), tryglycerides (TG), and medication used—statin, metformin, Dipeptidyl peptidase-4 (DPP4) inhibitors and insulin.

Characteristic HC T2D
Age 56 ± 10.30 63 ± 12.25
Sex (F/M) 10/5 9/6
BMI 24.8 ± 2.25 31 ± 4.29
Blood pressure (mmHg): systolic 110 ± 2.10 138.5 ± 2.8
Blood pressure (mmHg): diastolic 62 ± 1.99 88.1 ± 1.3
HbA1c (%) 5.4 ± 0.19 6.5 ± 0.6
HDL (mg/dL) 65 ± 3.99 47 ± 6.55
LDL (mg/dL) 97 ± 15.56 118 ± 27.67
TG (mg/dL) 88 ± 14.27 132 ± 48.47
Statin (number/total) 2/15 3/15
Metformin (number/total) n/a 15/15
DPP4 inhibitors n/a 2/15
Insulin n/a 0/15